Skip to main content
PTCT logo
PTCT
(NASDAQ)
PTC Therapeutics, Inc.
$67.77-- (--)
Loading... - Market loading

PTC Therapeutics (PTCT) Stock Price & Financial Analysis

PTC Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$67.04 - $68.70
52-Week High$87.50
52-Week Low$35.95
Open$67.32
Volume482.97K
Average Volume (3M)482.97K
Market Cap5.98B
Shares Outstanding88.31M
P/E Ratio (TTM)8.89
Price to Sales (P/S)3.51
EV/EBITDA6.29
Revenue (TTM)1.73B
Net Income (TTM)682.64M
Free Cash Flow (TTM)446.10M
EPS (TTM)$8.46
Profit Margin39.44%
Operating Margin49.49%
50-Day MA$69.50
200-Day MA$64.36
52-Week Change47.53%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About PTC Therapeutics

What is the current stock price for PTCT?

As of the latest trading session, PTCT stock trades at $67.77. The 52-week range is $35.95–$87.50, with a day range of $67.04–$68.70.

What is the P/E ratio for PTCT?

PTC Therapeutics's trailing P/E ratio is 8.9, meaning investors pay $8.9 for every $1 of annual earnings. PTC Therapeutics operates in the Healthcare sector.

Does PTCT pay dividends?

PTC Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PTCT?

Based on 6 analysts, the consensus for PTCT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PTCT?

PTC Therapeutics's market capitalization is $5.98B, classifying it as a mid-cap company. PTC Therapeutics operates in the Healthcare sector within the Biotechnology industry.